|
DE2438350C3
(de)
*
|
1974-08-09 |
1979-06-13 |
Hoechst Ag, 6000 Frankfurt |
Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
AU497512B2
(en)
*
|
1975-04-15 |
1978-12-14 |
Ici Australia Limited |
Nona and deca-peptides
|
|
US4215038A
(en)
*
|
1978-10-16 |
1980-07-29 |
The Salk Institute For Biological Studies |
Peptides which inhibit gonadal function
|
|
US4234571A
(en)
*
|
1979-06-11 |
1980-11-18 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
|
|
US4318905A
(en)
*
|
1980-06-23 |
1982-03-09 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues
|
|
ZA815447B
(en)
*
|
1980-08-29 |
1982-08-25 |
Salk Inst For Biological Studi |
Peptides affecting gonadal function
|
|
PH19942A
(en)
*
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
US4675189A
(en)
*
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
IE52535B1
(en)
*
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
WO1983002272A1
(en)
*
|
1981-12-28 |
1983-07-07 |
Beckman Instruments Inc |
Synthetic peptides having pituitary growth hormone releasing activity
|
|
JPS58125819U
(ja)
*
|
1982-02-19 |
1983-08-26 |
名伸電機株式会社 |
積算電力量計用パツキン
|
|
US4481190A
(en)
*
|
1982-12-21 |
1984-11-06 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
|
|
US4667014A
(en)
*
|
1983-03-07 |
1987-05-19 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
|
|
US4581169A
(en)
*
|
1982-12-21 |
1986-04-08 |
Syntex (U.S.A.) Inc. |
Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
|
|
US4663435A
(en)
*
|
1982-12-06 |
1987-05-05 |
Merck & Co., Inc. |
Bridged cyclic hexapeptide somatostatin analogs
|
|
US4581168A
(en)
*
|
1983-02-21 |
1986-04-08 |
Sanofi |
Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
|
|
US4530920A
(en)
*
|
1983-11-07 |
1985-07-23 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
|
|
US4897268A
(en)
*
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
JP2653255B2
(ja)
|
1990-02-13 |
1997-09-17 |
武田薬品工業株式会社 |
長期徐放型マイクロカプセル
|
|
CA2050425A1
(en)
|
1990-09-03 |
1992-03-04 |
Yoshiaki Uda |
Pharmaceutical composition and its mucous use
|
|
ZA918168B
(en)
|
1990-10-16 |
1993-04-14 |
Takeda Chemical Industries Ltd |
Prolonged release preparation and polymers thereof.
|
|
US6313146B1
(en)
|
1991-08-23 |
2001-11-06 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6031003A
(en)
*
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US5763569A
(en)
*
|
1991-08-23 |
1998-06-09 |
The Brigham And Women's Hospital, Inc |
Calcium receptor-active molecules
|
|
US5688938A
(en)
*
|
1991-08-23 |
1997-11-18 |
The Brigham & Women's Hospital, Inc. |
Calcium receptor-active molecules
|
|
US6011068A
(en)
*
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US5518730A
(en)
*
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
|
DE69316101T2
(de)
|
1992-08-07 |
1998-10-22 |
Takeda Chemical Industries Ltd |
Herstellung von Mikrokapseln, die wasserlösliche Arzneimittel enthalten
|
|
US5962314A
(en)
*
|
1993-02-23 |
1999-10-05 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
|
US5594091A
(en)
*
|
1994-02-21 |
1997-01-14 |
Takeda Chemical Industries, Ltd. |
Matrix for sustained-release preparation
|
|
EP0804593A1
(en)
*
|
1994-05-10 |
1997-11-05 |
Mayo Foundation For Medical Education And Research |
Recombinant hk2 polypeptide
|
|
US6117455A
(en)
|
1994-09-30 |
2000-09-12 |
Takeda Chemical Industries, Ltd. |
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
|
|
ES2234768T3
(es)
|
1994-10-21 |
2005-07-01 |
Nps Pharmaceuticals, Inc. |
Compuestos capaces de modular la actividad del receptor de calcio.
|
|
US5837281A
(en)
|
1995-03-17 |
1998-11-17 |
Takeda Chemical Industries, Ltd. |
Stabilized interface for iontophoresis
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
ATE243186T1
(de)
|
1996-05-01 |
2003-07-15 |
Nps Pharma Inc |
Verbindungen , die auf anorganische ionen- rezeptoren wirken
|
|
CA2208336A1
(en)
*
|
1996-06-20 |
1997-12-20 |
Hisamitsu Pharmaceuticals Co., Inc. |
A device structure for iontophoresis
|
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
|
US6235486B1
(en)
|
1997-06-20 |
2001-05-22 |
Mayo Foundation For Medical Education & Research |
Method for detection of breast cancer
|
|
US6737408B1
(en)
|
1997-08-07 |
2004-05-18 |
University Of Cincinnati |
Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
|
|
US6087128A
(en)
*
|
1998-02-12 |
2000-07-11 |
Ndsu Research Foundation |
DNA encoding an avian E. coli iss
|
|
US6803448B1
(en)
*
|
1998-07-22 |
2004-10-12 |
Vanderbilt University |
GBS toxin receptor
|
|
US8609614B2
(en)
*
|
1998-07-22 |
2013-12-17 |
Vanderbilt University |
GBS toxin receptor compositions and methods of use
|
|
US6339062B1
(en)
|
1998-11-23 |
2002-01-15 |
Inkine Pharmaceutical Company, Inc. |
Retroinverso polypeptides that mimic or inhibit thrombospondin activity
|
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
|
US20050042679A1
(en)
*
|
1999-04-15 |
2005-02-24 |
Monash University |
Diagnostic indicator of thymic function
|
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
|
WO2001010892A2
(en)
*
|
1999-08-06 |
2001-02-15 |
Genentech, Inc. |
Peptide antagonists of factor viia
|
|
US6407211B1
(en)
|
1999-12-17 |
2002-06-18 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides
|
|
CA2921260A1
(en)
*
|
1999-12-24 |
2001-06-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
EP1757311B1
(en)
|
1999-12-24 |
2009-02-11 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20060228364A1
(en)
*
|
1999-12-24 |
2006-10-12 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
US20050287153A1
(en)
*
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
US20040001827A1
(en)
*
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
|
US7164002B2
(en)
|
2002-02-06 |
2007-01-16 |
Genentech, Inc. |
FVIIa antagonists
|
|
US7968080B2
(en)
|
2003-08-20 |
2011-06-28 |
The Regents Of The University Of California |
Somatostatin analogs with inhibitory activity to growth hormone release
|
|
CA2539322C
(en)
*
|
2003-09-18 |
2016-07-12 |
Raven Biotechnologies, Inc. |
Kid3 and kid3 antibodies that bind thereto
|
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
|
JP4390568B2
(ja)
*
|
2004-01-19 |
2009-12-24 |
富士通株式会社 |
遅延測定システム
|
|
WO2005121179A2
(en)
*
|
2004-06-07 |
2005-12-22 |
Raven Biotechnologies, Inc. |
Transferrin receptor antibodies
|
|
MX2007003907A
(es)
*
|
2004-10-05 |
2007-05-21 |
Genentech Inc |
Agentes terapeuticos con toxicidad reducida.
|
|
US7687242B2
(en)
|
2005-01-12 |
2010-03-30 |
Raven Biotechnologies, Inc. |
KID31 and antibodies that bind thereto
|
|
US7847070B2
(en)
*
|
2005-01-31 |
2010-12-07 |
Raven Biotechnologies, Inc. |
LUCA2 and antibodies that bind thereto
|
|
US20060171952A1
(en)
*
|
2005-02-02 |
2006-08-03 |
Mather Jennie P |
JAM-3 and antibodies that bind thereto
|
|
MX2007009222A
(es)
*
|
2005-02-02 |
2008-01-16 |
Raven Biotechnologies Inc |
Moduladores de adam-9.
|
|
AU2006210606B2
(en)
*
|
2005-02-03 |
2012-03-22 |
Macrogenics West, Inc. |
Antibodies to Oncostatin M receptor
|
|
EP1790656A1
(en)
*
|
2005-11-25 |
2007-05-30 |
Nanokem S.A. |
Solution-phase synthesis of leuprolide
|
|
US20070197445A1
(en)
*
|
2006-01-18 |
2007-08-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
WO2008066691A2
(en)
|
2006-11-08 |
2008-06-05 |
Macrogenics West, Inc. |
Tes7 and antibodies that bind thereto
|
|
US8420077B2
(en)
|
2009-04-20 |
2013-04-16 |
Allergan, Inc. |
Silk fibroin hydrogels and uses thereof
|
|
PL219569B1
(pl)
|
2010-02-19 |
2015-05-29 |
Peptaderm Spółka Z Ograniczoną Odpowiedzialnością |
Cykliczne tetrapeptydy i ich zastosowanie
|
|
CN102892426B
(zh)
|
2010-03-04 |
2016-08-31 |
宏观基因有限公司 |
与b7-h3反应性的抗体、其免疫学活性片段及其用途
|
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
|
EP2714733B1
(en)
|
2011-05-21 |
2019-01-23 |
MacroGenics, Inc. |
Cd3-binding molecules capable of binding to human and non-human cd3
|
|
EP2557163A1
(en)
|
2011-08-12 |
2013-02-13 |
SymbioGruppe GmbH & Co KG |
Bacterially formed microcin S, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic Escherichia coli (EHEC)
|
|
EP2748182B1
(en)
|
2011-08-23 |
2016-10-19 |
President and Fellows of Harvard College |
Peptide nanoparticles and uses thereof
|
|
CN103906761B
(zh)
|
2011-08-30 |
2016-12-21 |
梅约医学教育与研究基金会 |
利钠多肽
|
|
WO2013103896A1
(en)
|
2012-01-06 |
2013-07-11 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
|
WO2014159940A1
(en)
|
2013-03-14 |
2014-10-02 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
|
|
US20160106813A1
(en)
|
2013-03-29 |
2016-04-21 |
Centre National De La Recherche Schientifique (Cnrs) |
Cgrp receptor agonist for hiv treatment or prevention
|
|
AU2015266797C1
(en)
|
2014-05-29 |
2019-04-04 |
Macrogenics, Inc. |
Tri-Specific Binding Molecules that specifically bind to multiple Cancer Antigens and methods of use thereof
|
|
US10717778B2
(en)
|
2014-09-29 |
2020-07-21 |
Duke University |
Bispecific molecules comprising an HIV-1 envelope targeting arm
|
|
TWI773646B
(zh)
|
2015-06-08 |
2022-08-11 |
美商宏觀基因股份有限公司 |
結合lag-3的分子和其使用方法
|
|
PL3328419T3
(pl)
|
2015-07-30 |
2021-12-27 |
Macrogenics, Inc. |
Cząsteczki wiążące pd-1 i sposoby ich zastosowania
|
|
AU2016334041B2
(en)
|
2015-10-08 |
2023-02-09 |
Macrogenics, Inc. |
Combination therapy for the treatment of cancer
|
|
WO2017096017A1
(en)
|
2015-12-02 |
2017-06-08 |
Stsciences, Inc. |
Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator)
|
|
MX2018007089A
(es)
|
2015-12-14 |
2019-01-30 |
Macrogenics Inc |
Moleculas biespecificas que tienen inmunorreactividad con pd-1 y ctla-4, y metodos de uso de las mismas.
|
|
WO2017180813A1
(en)
|
2016-04-15 |
2017-10-19 |
Macrogenics, Inc. |
Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof
|
|
US10111929B1
(en)
|
2017-04-07 |
2018-10-30 |
Ez Ip, Llc |
Growth hormone releasing factor analogs and uses
|
|
US20220411511A1
(en)
|
2019-09-26 |
2022-12-29 |
Stcube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
|
CN114829404A
(zh)
|
2019-10-09 |
2022-07-29 |
斯特库比公司 |
对糖基化的lag3特异的抗体及其使用方法
|
|
US11596665B2
(en)
|
2020-06-23 |
2023-03-07 |
Chanda Zaveri |
Skin lightening formulations
|
|
US11951203B2
(en)
|
2020-08-26 |
2024-04-09 |
Chanda Zaveri |
Deep wrinkle vanishing compositions
|
|
US11793746B2
(en)
|
2020-10-01 |
2023-10-24 |
Chanda Zaveri |
Intense skin hydration systems and methods
|
|
US20220110852A1
(en)
|
2020-10-14 |
2022-04-14 |
Chanda Zaveri |
Pigment Stabilizers
|